Eastern Cooperative Oncology Group

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 2012-01-01

Employees: 51

Market Cap: -

Website: https://ecog-acrin.org

Clinical Trials

Paclitaxel in Treating Patients With Advanced Head and Neck Cancer

Phase 2

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2004-07-07

Last Posted Date: 2023-06-18

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00002922

Locations: 🇺🇸
Veterans Affairs Medical Center - Atlanta (Decatur), Decatur, Georgia, United States
🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
🇺🇸
Veterans Affairs Medical Center - Chicago (Lakeside), Chicago, Illinois, United States

and more 21 locations

Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer

Phase 2

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2004-06-16

Last Posted Date: 2023-06-15

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00003206

Locations: 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
Veterans Affairs Medical Center - Palo Alto, Palo Alto, California, United States
🇺🇸
Stanford University Medical Center, Stanford, California, United States

and more 15 locations

PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

First Posted Date: 2004-06-16

Last Posted Date: 2023-06-22

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 60

Registration Number: NCT00003871

Locations: 🇺🇸
University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States
🇺🇸
Indiana University Cancer Center, Indianapolis, Indiana, United States
🇺🇸
Veterans Affairs Medical Center - Indianapolis (Roudebush), Indianapolis, Indiana, United States

and more 7 locations

Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer

Phase 3

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2004-06-16

Last Posted Date: 2023-06-22

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 230

Registration Number: NCT00003592

Locations: 🇺🇸
Veterans Affairs Medical Center - Atlanta (Decatur), Decatur, Georgia, United States
🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
🇺🇸
CCOP - Kalamazoo, Kalamazoo, Michigan, United States

and more 17 locations

Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer

Phase 3

Completed

Conditions: Breast Cancer

First Posted Date: 2004-06-10

Last Posted Date: 2012-01-05

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 1500

Registration Number: NCT00002646

Locations: 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸
Beckman Research Institute, City of Hope, Los Angeles, California, United States
🇺🇸
CCOP - Atlanta Regional, Atlanta, Georgia, United States

and more 82 locations

Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer

Phase 2

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2004-06-10

Last Posted Date: 2023-06-15

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 32

Registration Number: NCT00002632

Locations: 🇺🇸
Johns Hopkins Oncology Center, Baltimore, Maryland, United States
🇺🇸
Hahnemann University Hospital, Philadelphia, Pennsylvania, United States
🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

and more 26 locations

Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer

Phase 2

Completed

Conditions: Kidney Cancer

First Posted Date: 2004-06-09

Last Posted Date: 2013-06-21

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00005045

Locations: 🇺🇸
Allegheny University, Philadelphia, Pennsylvania, United States
🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
CCOP - Columbus, Columbus, Ohio, United States

and more 52 locations

Chemotherapy in Treating Women With Previously Treated Metastatic Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

First Posted Date: 2004-06-09

Last Posted Date: 2023-06-18

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00003236

Locations: 🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
🇺🇸
Veterans Affairs Medical Center - Chicago (Lakeside), Chicago, Illinois, United States
🇺🇸
Johns Hopkins Oncology Center, Baltimore, Maryland, United States

and more 3 locations

Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors

Phase 2

Completed

Conditions: Ovarian Cancer
Testicular Germ Cell Tumor

First Posted Date: 2004-05-24

Last Posted Date: 2023-06-22

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 44

Registration Number: NCT00003518

Locations: 🇺🇸
CCOP - Kalamazoo, Kalamazoo, Michigan, United States
🇺🇸
Hahnemann University Hospital, Philadelphia, Pennsylvania, United States
🇺🇸
CCOP - Ochsner, New Orleans, Louisiana, United States

and more 16 locations

Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

First Posted Date: 2004-05-24

Last Posted Date: 2023-06-15

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00003614

Locations: 🇺🇸
CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States
🇺🇸
University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

and more 25 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy